Management of BU-HIV co-infection
作者： D. P. O'Brien , N. Ford , M. Vitoria , V. Christinet , E. Comte
DOI: 10.1111/TMI.12342
关键词:
摘要: In many Buruli ulcer (BU) endemic countries worldwide there is also a high HIV prevalence. This especially the case in Africa with adult prevalence rates between 1 and 5% BU countries. Evidence from Benin, Cameroon, Ghana Gabon suggest that may increase risk of [1–5]. For example, Medecins Sans Frontieres programme Akonolinga, was approximately 3–6 times higher treated patients compared to regional estimated (37% vs 8% women; 20% men; 4% 0.7% children) [2]. Likewise one region were eight more likely have infection than those without (2.6% 0.3%) [3], another adults five (5.0% 1.1%) [4]. 4–5 (5% 0.9% study 8.2% 2.5% study) [1, 6]. Therefore, significant potential for two infections overlap same individual needs be considered all settings background
core.ac.uk
springer.com
archives-ouvertes.fr
sci-hub.se 参考文章(41)
Daniel P. O’Brien, Eric Comte, Nathan Ford, Vanessa Christinet, Philipp du Cros, Moxifloxacin for Buruli ulcer/HIV coinfected patients: kill two birds with one stone? AIDS. ,vol. 27, pp. 2177- 2179 ,(2013) , 10.1097/QAD.0B013E32836268F4
Harry S. Thangaraj, Mark R.W. Evans, Mark H. Wansbrough-Jones, Mycobacterium ulcerans disease; Buruli ulcer Transactions of The Royal Society of Tropical Medicine and Hygiene. ,vol. 93, pp. 337- 340 ,(1999) , 10.1016/S0035-9203(99)90104-9
Sydney Rosen, Matthew P. Fox, Retention in HIV Care between Testing and Treatment in Sub-Saharan Africa: A Systematic Review PLOS Medicine. ,vol. 8, ,(2011) , 10.1371/JOURNAL.PMED.1001056
R. J. Wallace, B. A. Brown, D. E. Griffith, W. Girard, K. Tanaka, Reduced serum levels of clarithromycin in patients treated with multidrug regimens including rifampin or rifabutin for Mycobacterium avium-M. intracellulare infection. The Journal of Infectious Diseases. ,vol. 171, pp. 747- 750 ,(1995) , 10.1093/INFDIS/171.3.747
Quentin B Vincent, Marie-Françoise Ardant, Laurent Marsollier, Annick Chauty, Alexandre Alcaïs, HIV infection and Buruli ulcer in Africa The Lancet Infectious Diseases. ,vol. 14, pp. 796- 797 ,(2014) , 10.1016/S1473-3099(14)70882-5
Haileyesus Getahun, Wanitchaya Kittikraisak, Charles M. Heilig, Elizabeth L. Corbett, Helen Ayles, Kevin P. Cain, Alison D. Grant, Gavin J. Churchyard, Michael Kimerling, Sarita Shah, Stephen D. Lawn, Robin Wood, Gary Maartens, Reuben Granich, Anand A. Date, Jay K. Varma, Development of a Standardized Screening Rule for Tuberculosis in People Living with HIV in Resource-Constrained Settings: Individual Participant Data Meta-analysis of Observational Studies PLoS Medicine. ,vol. 8, pp. e1000391- ,(2011) , 10.1371/JOURNAL.PMED.1000391
Franck Wanda, Patrick Nkemenang, Genevieve Ehounou, Marie Tchaton, Eric Comte, Laurence Toutous Trellu, Isabelle Masouyé, Vanessa Christinet, Daniel P O’Brien, Clinical features and management of a severe paradoxical reaction associated with combined treatment of Buruli ulcer and HIV co-infection BMC Infectious Diseases. ,vol. 14, pp. 423- 423 ,(2014) , 10.1186/1471-2334-14-423
P. L. Raghunathan, E. A. S. Whitney, K. Asamoa, Y. Stienstra, T. H. Taylor, G. K. Amofah, D. Ofori-Adjei, K. Dobos, J. Guarner, S. Martin, S. Pathak, E. Klutse, S. Etuaful, W. T. A. van der Graaf, T. S. van der Werf, C. H. King, J. W. Tappero, D. A. Ashford, Risk factors for Buruli ulcer disease (Mycobacterium ulcerans infection): Results from a case-control study in Ghana Clinical Infectious Diseases. ,vol. 40, pp. 1445- 1453 ,(2005) , 10.1086/429623
A. Toll, F. Gallardo, M. Ferran, M. Gilaberte, M. Iglesias, J. L. Gimeno, S. Rondini, R. M. Pujol, Aggressive multifocal Buruli ulcer with associated osteomyelitis in an HIV-positive patient. Clinical and Experimental Dermatology. ,vol. 30, pp. 649- 651 ,(2005) , 10.1111/J.1365-2230.2005.01892.X
J. W. C. Alffenaar, W. A. Nienhuis, F. de Velde, A. T. Zuur, A. M. A. Wessels, D. Almeida, J. Grosset, O. Adjei, D. R. A. Uges, T. S. van der Werf, Pharmacokinetics of Rifampin and Clarithromycin in Patients Treated for Mycobacterium ulcerans Infection Antimicrobial Agents and Chemotherapy. ,vol. 54, pp. 3878- 3883 ,(2010) , 10.1128/AAC.00099-10